Characterization and purification of a bacteriocin produced by a potential probiotic culture, Lactobacillus acidophilus. by S Oh et al.
Characterization and Purification of a Bacteriocin Produced by a
Potential Probiotic Culture, Lactobacillus acidophilus 30SC
S. Oh,* S. H. Kim,† and R. W. Worobo*
*Department of Food Science & Technology,
New York State Agricultural Experiment Station,
Cornell University, Geneva, NY 14456-0462
†Department of Animal Science,
Korea University, Seoul 136-701, Korea
ABSTRACT
Lactobacillus acidophilus 30SC was tested for its po-
tential as a probiotic culture. The strain exhibited good
acid tolerance in an artificial gastric solution as well
as bile resistance in media containing 0.3% bile acids.
The strain produced a heat-stable antimicrobial com-
pound that was shown to be proteinaceous in nature
and, therefore, referred to as a bacteriocin. The bacte-
riocin was active over a wide pH range and inhibited
a number of Gram-positive bacteria including Listeria
ivanovii and pathogenic strains. The bacteriocin was
purified by 50% ammonium sulfate precipitation fol-
lowed by hydrophobic interaction column chromatogra-
phy. The SDS-PAGE of the active fractions resulted in
a single band with estimated molecular mass of 3.5
kDa. These results demonstrate the potential of L. acid-
ophilus 30SC as a probiotic culture that can be utilized
in the manufacturing of dairy foods and dietary sup-
plements.
(Key words: probiotics, bacteriocin, Lactobacillus
acidophilus)
Abbreviation key: LAB = lactic acid bacteria
INTRODUCTION
Intestinal lactic acid bacteria (LAB) for humans are
closely associated with the host’s health because LAB
is an important biodefense factor in preventing coloni-
zation and subsequent proliferation of pathogenic bac-
teria in the intestine (7, 18). A probiotic is defined as
“a live microbial feed supplement which beneficially
affects the host animal by improving its intestinal mi-
crobial balance” (4). Some species of LAB have been
claimed as probiotics, such as Lactobacillus acido-
philus, Lactobacillus delbrueckii subsp. bulgaricus,
Lactobacillus casei, Lactobacillus fermentum, Lactoba-
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cillus plantarum, and Lactobacillus reuteri, and Bifid-
obacterium species. To be considered as probiotics,
these bacteria should become a part of the normal mi-
crobial flora in the intestine, survive the gastrointesti-
nal passage, and be able to adhere and colonize the
intestinal tract (9).
The gastrointestinal tract of a healthy human is a
harsh environment because it contains gastric juices,
digestive enzymes, and bile acids. These conditions im-
pose a significant threat to probiotic strains. In addi-
tion, low surface tension and immune response also
affect the survival of probiotic strains (5). Lactobacillus
acidophilus strains are widely used as probiotic cul-
tures in dairy and pharmaceutical products because
this species is one of the dominant lactobacilli in the
human intestine (21).
Since one hundred trillion individual bacteria of 100
different varieties inhabit the intestine (16), it is chal-
lenging for probiotic strains to become established as
gastrointestinal microflora. Thus, organisms that can
produce a product that will inhibit the growth or kill
existing organisms in the intestinal milieu have a dis-
tinct advantage (7).
LAB produce a number of antimicrobial substances,
including organic acids, hydrogen peroxide, bacterio-
cins, and bacteriocin-like substances. Bacteriocins or
bacteriocin-like substances are peptides or proteins,
which exhibit inhibitory activity against sensitive
strains of bacteria (11, 17). Antimicrobial peptides have
been found to be widely distributed in microorganisms
as well as some insects and rodents (17). Numerous
LAB bacteriocins have been extensively studied. Bacte-
riocins have been grouped into three main classes based
on their chemical and genetic properties (14). The first
class, the lantibiotics, comprises small peptides with
dehydrated or modified residues such as dehydroalan-
ine and lanthionine (13). The second class includes
small heat stable bacteriocins such as pediocin A, leu-
cocin A, lactacin F, lactococcins, and carnobacteriocin
A, BM1 and B2 (11). The third group comprises large
heat labile bacteriocins such as helveticin J (14).
Some bacteriocins that are produced by strains of
L. acidophilus have been purified and characterized
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including acidocin 8912 (24), lactacin B (2), acidophilin
(23), acidolin (8), and lactocidine (25). However, few of
these strains have been extensively studied for their
potential probiotic use.
The purpose of this study was to evaluate the poten-
tial of L. acidophilus strains as a probiotic culture by
characterizing the acid and bile tolerance as well as the
bacteriocin produced by these strains in vitro.
MATERIALS AND METHODS
Bacterial Strains
Lactobacillus acidophilus 30SC was obtained from
the Dairy Microbiology Laboratory in Oklahoma State
University. L. delbrueckii subsp. lactis 4797 and patho-
genic bacteria were obtained from American Type Cul-
ture Collections. LAB were grown for 18 h at 37°C in
MRS broth (Difco, Detroit, MI), and the pathogens were
incubated in trypticase soy broth (Difco) at either 30 or
37°C for 18 to 24 h. The strains were subcultured three
times before use. Cultures were stored at –70°C in 10%
skim milk with 30% glycerol as a cryoprotectant.
Acid Tolerance
The artificial gastric juice was prepared by supple-
menting MRS broth (Difco) with pepsin (Sigma Chemi-
cal Co., St. Louis. MO). The MRS broth was prepared
by adjusting to pH 2.5 with 1N HCl and was then steri-
lized by autoclaving for 15 min at 121°C. The pepsin
solution was filter sterilized using a 0.22-µm membrane
filter and was then added to MRS broth (pH 2.5) to a
final concentration of 1000 units/ml.
The strains were incubated at 37°C for 18 h and then
centrifuged (4,000 × g for 10 min, 4°C). The collected
cells were then resuspended in sterile saline (0.85%
NaCl). The cells were inoculated at 106 cfu/ml into arti-
ficial gastric juice and incubated at 37°C for 1, 2, and
3 h, respectively. The bacterial counts were determined
with MRS plates containing 2% β-glycerophosphate
(Sigma Chemical Co.).
Bile Tolerance
Bile tolerance was determined in MRS broth con-
taining 0.3% bile acids (oxgall; Difco). Before testing
for bile tolerance, all strains were incubated at 37°C
for 18 h in MRS broth without bile. After centrifugation
(4,000 × g for 10 min, 4°C), the collected cells were
resuspended in sterile saline (0.85% NaCl) and then
inoculated into MRS broth containing 0.3% bile acids.
Cultures were incubated at 37°C. The bacteria were
plated and enumerated after 24 and 48 h of incubation.
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Bacteriocin Production and Activity
The five strains of L. acidophilus were screened for
bacteriocin production against a range of indicator bac-
teria (Table 1) using the spot-on-lawn assay (1). Before
testing, cells were removed from the growth medium
by centrifugation (6,000 × g for 20 min, 4°C). Bacteriocin
activity was quantitated by spotting 20-µl aliquots of
twofold serial dilutions of the culture supernatant that
was adjusted to pH 6.5 using 10N NaOH and spotted
onto the surface of MRS agar. The spotted agar was
then overlayed with 0.8% MRS agar inoculated with
1% of the indicator strain, Leuconostoc sp. K2 isolated
from Kimchee, a traditional Korean fermented cabbage
product. The plates were incubated at 37°C for 24 h.
The bacteriocin activity was determined by the highest
twofold dilution showing a clear inhibition zone on the
MRS agar.
Sensitivity to heat, pH, and proteases
Samples of crude bacteriocin were used for these
tests. Aliquots of the semi-purified bacteriocin were ex-
posed to heat treatments of 65°C for 40 min, 95°C for
20 min, and 121°C for 20 min, and then were tested for
remaining antimicrobial activity. Semipurified prepa-
rations of the bacteriocin were adjusted to various pH
values in the range of 3 to 10. The pH-adjusted bacterio-
cin samples were incubated at 37°C for 20 min and then
neutralized to pH 6 and tested for bacteriocin activity.
Susceptibility of bacteriocin to various proteases was
performed by incubating the bacteriocin preparation in
the presence of pronase E (1 mg/ml) and proteinase K
(1 mg/ml) at 37°C for 1 h. After incubation, the enzymes
were inactivated by heat treatment at 65°C for 30 min
and tested for bacteriocin activity.
Purification of Bacteriocin
Culture supernatant was obtained by centrifugation
(8,000 × g for 30 min, 4°C) of L. acidophilus 30SC inocu-
lated MRS broth incubated at 37°C for 24 h. Ammonium
sulfate was added to reach 50% (wt/vol) and allowed to
stir overnight at 4°C. The ammonium sulfate precipi-
tate was collected by centrifugation at 10,000 × g for
20 min and resuspended with 2-(4-morpholino)-ethane
sulfonic acid (FisherBiotech, Fair Lawn, NJ) buffer (50
mM, pH 6.5). The crude bacteriocin solution was sub-
jected to hydrophobic interaction column chromatogra-
phy using Octyl-Sepharose CL-4B (Pharmacia Biotec
AB, Uppsala, Sweden). The column was equilibrated
with 1.7 M (NH4)2SO4 and then eluted with a linear
increasing gradient using H2O and ethanol at a flow
rate of 1 ml/min. The absorbance was a monitored at
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Table 1. Antimicrobial spectrum of crude bacteriocin from Lactobacillus acidophilus 30SC against Gram-
positive and Gram-negative bacteria.
Bacteria Inhibition1 Reference
Gram-positive
Bacillus cereus ATCC1 1778 + ATCC
Bacillus subtilis 1A650 + (20)
B. subtilis 1A651 + (20)
Lactobacillus acidophilus ATCC 43121 − ATCC
Lactobacillus casei Y2 + Lab. isolate
Lactobacillus delbruekii subsp. lactis ATCC 4797 + ATCC
Lactobacillus fermentum ATCC 11931 + ATCC
Lactobacillus helveticus 1213 − Lab. isolate
Lactobacillus plantarum + Lab. isolate
Lactococcus lactis ATCC 1145 − ATCC
Lactococcus sp. CU216 − Lab. isolate
Leuconostoc sp. K2 + Lab. isolate
Listeria innocua − Lab. isolate
Listeria ivanovii + Lab. isolate
Listeria monocytogenes − Lab. isolate
Staphylococcus aureus + Lab. isolate
Streptococcus faecalis − Lab. isolate
Gram-negative
Acinetobacter baumani − Lab. isolate
Escherichia coli O157 ATCC 43889 − ATCC
E. coli O157 ATCC 43893 − ATCC
E. coli O157 ATCC 43894 − ATCC
E. coli O157 ATCC 43895 − ATCC
Klebsiella pneumoniae − Lab. isolate
Salmonella typhimurium − Lab. isolate
Yersinia enterocolitica − Lab. isolate
1+, Inhibited by crude bacteriocin; − not inhibited. ATCC, American Type Culture Collection.
280 nm and bacteriocin activity of each fraction was
determined by the spot-on-lawn assay.
SDS-PAGE
Active fractions from the Octyl-sepharose CL-4B col-
umn were pooled and concentrated by rotary evapora-
tion. The concentrated sample was electrophoresed on
16.5% tricine-SDS polyacrylamide gel (22). A duplicate
gel was washed three times in 250 ml of H2O for 30
min, and the gel was placed onto MRS agar medium
and overlayed with soft MRS agar inoculated with 1%
Leuconostoc sp. K2.
RESULTS
Acid and Bile Tolerances
All experiments were replicated four times, and each
viable cell count was performed in duplicate. As shown
in Figure 1, a relatively high population of L. acido-
philus survived under acidic conditions. Lactobacillus
acidophilus NCFM was found to be the least acid toler-
ant, with a final population of 6.0 × 104 cfu/ml, whereas
the population of L. acidophilus 30SC and ATCC 43121
remained relatively constant.
As shown in Figure 2, all five strains of L. acidophilus
exhibited excellent bile tolerance. Lactobacillus acido-
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Figure 1. Acid tolerance of Lactobacillus acidophilus strains. L.
acidophilus 30SC (), L. acidophilus ATCC 4356 (), L. acidophilus
ATCC 43121 (*), L. acidophilus GP1B (▲), L. acidophilus NCFM (◆ ).
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Figure 2. Bile tolerance of Lactobacillus acidophilus strains. L.
acidophilus 30SC (), L. acidophilus ATCC 4356 (), L. acidophilus
ATCC 43121 (*), L. acidophilus GP1B (▲), L. acidophilus NCFM (◆ ).
philus ATCC 43121 showed enhanced growth in media
containing 0.3% bile acids after 24 h of incubation, while
L. acidophilus 30SC survived at a level of 7.0 × 105 cfu/
ml under the same conditions.
Inhibitory Spectrum
Only L. acidophilus 30SC was found to produce a
bacteriocin that displayed antimicrobial activity
against some of the tested indicator strains (Table 1).
The bacteriocin produced by L. acidophilus 30SC was
capable of inhibiting Gram-positive pathogenic bacteria
including Bacillus cereus ATCC 11778, Listeria iva-
novii, and Staphylococcus aureus. Other Gram-positive
strains inhibited were primarily LAB. Like other LAB
bacteriocins, the L. acidophilus 30SC bacteriocin did
not inhibit Gram-negative bacteria.
Effects of Enzymes, pH, and
Heat on the Bacteriocin
Partially purified bacteriocin was found to be sensi-
tive to pronase E and proteinase K, but a bacteriocin
solution treated with catalase did not affect the activity
(Table 2). The fact that catalase had no effect on the
bacteriocin inhibitory activity suggests that the inhibi-
tion is not due to hydrogen peroxide. These data indi-
cate that the inhibitory substance is proteinaceous in
nature. Inhibitory activity was unaffected by heating
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1Bacteriocin activity is expressed as the % of residual activity.
2The enzyme concentration was 1 mg/ml.
up to 95°C for 20 min, and 50% of activity still remained
after a heat treatment of 121°C for 20 min. The bacterio-
cin produced by L. acidophilus 30SC was completely
stable at pH 6 and 7, and 50% of activity remained
after subjection to the various pH values between 3
and 10.
Purification of Bacteriocin
The majority of the bacteriocin activity was eluted
at approximately 60% ethanol from Octyl-Sepharose
CL-4B, indicating that the antimicrobial compound is
hydrophobic in nature (Figure 3). SDS-PAGE of the
pooled active fractions resulted in a single band with
the estimated molecular mass of 3.5 kDa. Incubation
of the electrophoresed gel on the agar seeded with indi-
Figure 3. Elution pattern of Lactobacillus acidophilus 30SC bacte-
riocin on Octyl-Sepharose CL4B. Absorbance at 280 nm (); Bacterio-
cin activity ().
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Figure 4. Tricine-SDS-PAGE and detection of antimicrobial activ-
ity of the purified Lactobacillus acidophilus 30SC bacteriocin. (A) gel
stained with Coomassie blue stain; lane 1, low molecular mass protein
standards (Bio-Rad, Hercules, CA); lane 2, purified L. acidophilus
30SC bacteriocin. (B) gel overlayed with cells of Leuconostoc sp K2
inoculated in MRS soft agar.
cator strain confirmed the inhibitory action of the cor-
responding protein band (Figure 4).
DISCUSSION
In general, strains of L. acidophilus exhibit more acid
and bile resistance than other lactic acid bacteria (5).
The strains of L. acidophilus tested in this study have
been isolated from feces from human or various animals
and showed acid resistance. The acid tolerance of LAB
is dependent upon the pH profile of H+-ATPase and
the composition of the cytoplasmic membrane, which
is largely influenced by the type of bacteria, type of
growth media, and the incubation conditions (9, 10).
Strains of L. acidophilus as well as the strains of L.
casei and L. plantarum have been shown to survive at
pH 3.0 or less. Some were able to pass through the
stomach without losing viability (10, 19). Because there
was significant correlation between in vivo and in vitro
experiments, the acid tolerance test with an artificial
gastric juice is frequently used to select for probiotic
strains.
Bile tolerance is one of the most essential criteria for
a strain to be used as a probiotic culture (5). Bile salts
are surface-active chemicals produced in the liver from
the catabolism of cholesterol. The bile acids consist of
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chenodeoxycholic acid, cholic acid, deoxycholic acid and
other minor components secreted from spleen into duo-
denum of the small intestine (3). Bile acids have been
shown to inhibit microorganisms and their inhibitory
activity is greater than organic acids (19). LAB isolated
from the intestine, do not grow well in the media con-
taining 0.15% bile acids (6). However, LAB isolated
from intestinal sources such as L. acidophilus and L.
casei, are capable of surviving in the presence of bile
due to their ability to deconjugate bile acids. Bile resis-
tance and the ability of LAB to inhabit the intestinal
tract appear to be correlated (6, 10).
L. acidophilus 30SC exhibited excellent acid resis-
tance and bile tolerance compared with commercial pro-
biotic strains that are presently used such as L. acido-
philus NCFM. For prolonged survival of probiotic
strains in the host body, LAB should have the ability
to colonize the intestine (7). Adherence and colonization
are considered important properties for probiotic
strains (9). Colonization of a probiotic strain in an al-
ready existing microbial ecosystem requires more than
adherence alone. Probiotics with the ability to compete
against other microorganisms, for example by the pro-
duction of antimicrobial substances, increases their
chance to colonize this ecosystem (9). The ability of
probiotics to establish themselves in the gastrointesti-
nal tract should enhance their ability to eliminate com-
petitors using bacteriocin(s).
The bacteriocin produced by L. acidophilus 30SC dis-
plays antimicrobial effects on bacteria such as Listeria
and Bacillus species; spore-forming bacteria, B. cereus
and B. subtilis were sensitive to the bacteriocin pro-
duced by L. acidophilus 30SC. The bacteriocin may
have potential use as a food additive in the food indus-
try, particularly processed food, in which some Bacillus
species are potential spoilage microorganisms.
The L. acidophilus 30SC bacteriocin was active over
a wide range of pH, and was stable to various heat
treatments. The loss of antimicrobial activity following
treatment with proteinase K and pronase E indicated
that the active component secreted extracellullarly by
L. acidophilus 30SC was proteinaceous in nature. Simi-
lar properties have been reported for other bacteriocins
including lactacin, lactacin 27, acidolin, pediocin A, and
pediocin PA-1 (11, 14). These bacteriocins were also
stable over a wide range of pH. This heat and pH stabil-
ity may be useful if the bacteriocin is to be used as an
antimicrobial agent in fermented foods or thermally
processed foods.
The molecular mass of the L. acidophilus 30SC bacte-
riocin was estimated at 3.5 kDa, whereas acidocin 8912
(24) and lactacin B (2) were reported to be 5.4 and 6.5
kDa, respectively. However, acidocin B migrated with
a molecular mass of 2.4 kDa on SDS-PAGE, but the
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molecular mass was subsequently calculated to be 5.8
kDa from its DNA sequence (15). Similarly, the molecu-
lar mass of gassericin A was estimated by SDS-PAGE
to be 3.8 kDa, but the mass spectroscopy showed that
the molecular mass of gassericin A is 5652 Da (12). To
characterize the structure and function of the bacterio-
cin produced by L. acidophilus 30SC, further investiga-
tion is required and is presently being performed.
In conclusion, L. acidophilus 30SC meets several of
the criteria for use as a probiotic culture, which includes
acid and bile tolerances, as well as the production of
antagonistic substances. These characteristics may be
advantageous for a probiotic culture to be successful
in colonizing and to compete with pathogens in the
gastrointestinal environment. The ability to survive
acidic conditions, bile resistance, and the production of
a bacteriocin that is active against food-related patho-
gens and spoilage microorganisms, contributes to the
ability of L. acidophilus 30SC as a probiotic culture
that may have potential applications in the production
of cultured foods and dietary adjuncts.
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